Monthly Research Seminar
The Tara Miller Melanoma Center hosts a monthly seminar series presented by Penn investigators and occasionally, speakers from other institutions. Held virtually at 1PM on first Wednesday of the month, these seminars enable investigators to share cutting edge research updates in melanoma and other cutaneous malignancies and identify opportunities for collaboration.
If you would like to attend or present at one of our research seminars, please contact Ahron Flowers.
2025 Schedule
| Date | Presenter | Presentation Title |
|---|---|---|
| January 1, 2025 | No meeting | New Year's Day holiday |
| February 5, 2025 | Keren Sturtz, MD | Next generation BRAFi & brain penetrant MEKi for melanoma |
| March 5, 2025 | Jeffery Ishizuka, MD, DPhil | Defining and targeting tumor inflammatory states |
| April 2, 2025 | Qing Chen, MD, PhD | Elucidating the impact of steroid exposure on BRAF-MEK Inhibitors in treating melanoma brain metastasis |
| May 7, 2025 | Leyuan Ma, PhD | Selective delivery of therapeutics via a robust hypoxia circuit for the treatment of melanoma |
| June 4, 2025 | open | |
| July 2, 2025 | No meeting | Independence Day holiday |
| August 6, 2025 | open | |
| September 3, 2025 | open | |
| October 1, 2025 | open | |
| November 5, 2025 | open | |
| December 3, 2025 | open |
2024 Schedule
| Date | Presenter | Presentation Title |
|---|---|---|
| January 3, 2024 | Noam Auslander, PhD | Gut microbial proteins predict adverse events and immune responses in melanoma |
| February 7, 2024 | Beatrice Carreno, PhD | Cancer neoantigens as targets for vaccines and T cell therapies |
| March 6, 2024 | Anushka Dheer | The immune microenvironment of the sentinel lymph node after neoadjuvant anti-PD1 treatment in stage IIB/C melanoma |
| April 3, 2024 | Alexander C. Huang, MD |
Next generation immune profiling in melanoma |
| May 1, 2024 | Cardio-oncology group | Observational study discussion: The pharmacodynamic effect of PD-1 blockade on cardiac function |
| June 5, 2024 | Otolaryngology group | ENT/Melanoma research collaboration discussion |
| July 3, 2024 | No meeting | Summer Break |
| August 7, 2024 |
Addison Browell (Student Intern) |
Understanding Melanoma in patient diagnosis, staging, and treatment |
| September 4, 2024 | Ravi Amaravadi, MD | Targeting melanoma driver mutations with RNA-LNP |
| October 2, 2024 | Emily Lebow, MD | TBD |
| November 6, 2024 | CANCELED | |
| December 4, 2024 | Alexander C. Huang, MD |
Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells |
2023 Schedule
| Date | Presenter | Presentation Title |
|---|---|---|
| January 4, 2023 | Leyuan Ma, PhD | Testing CAR binding to patient samples |
| February 1, 2023 | Saar I. Gill, MD, PhD | Transduction of tumor-infiltration lymphocytes with a chimeric cytokine receptor to replace the need for high-dose IL2/Genetic engineering of TILs |
| March 1, 2023 | Alexander C. Huang, MD | Antigen-specific immune profiling of CD8 T cells in neoadjuvant a-PD1 |
| April 5, 2023 | Yanxiang Deng, PhD | Advancing Biomedical Research with Spatial Omics Technologies |
| May 3, 2023 | Lindsey Behlman, MPH, MSW | Clinical Trials update--Samples, Trials, and Accrual Metrics & Goals |
| June 7, 2023 | Ravi K. Amaravadi, MD | Targeting UGCG to enhance antitumor immunity |
| July 7, 2023 | Summer Break | N/A |
| August 8, 2023 | Summer Break | N/A |
| September 6, 2023 | George Xu, MD, PhD | Designer extracellular vesicles-based therapy |
| October 4, 2023 | Sydney M Shaffer, MD, PhD | Mapping clonal dynamics and cell states in melanoma |
| November 1, 2023 | Understanding the immune-tumor interface through high-parameter immunofluorescence | |
| December 6, 2023 | Lindsey Behlman, MPH, MSW | Clinical Trials: A Year End Review |